查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574996

醫院獲得性疾病檢測市場，按感染類型、檢測技術、檢測類型、最終用戶、國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Hospital-Acquired Disease Testing Market, By Infection Type, By Testing Technology, By Test Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年醫院獲得性疾病檢測市場規模為122.9032億美元，2024年至2032年複合年成長率為15.90%。

醫院獲得性疾病檢測市場-市場動態

院內感染發生率的上升推動了醫院獲得性疾病檢測市場對先進檢測解決方案的需求

院內感染 (HAI) 發病率的上升大大增加了醫療保健環境中對先進檢測解決方案的需求。這些感染，如泌尿道感染 (UTI)、手術部位感染和血液感染，對患者健康構成嚴重風險，並導致住院時間延長和死亡率升高。據美國疾病管制與預防中心 (CDC) 稱，醫院感染每年影響數百萬患者，促使開發更精確、更快速的診斷工具。世界各地的政府和醫療機構已經發起了對抗醫院感染的措施。例如，世界衛生組織（WHO）推行嚴格的衛生規程，而英國等國家則對感染率高的醫院實施經濟處罰。人們越來越關注即時、準確的檢測方法，例如聚合酶鍊式反應 (PCR) 和快速診斷檢測，預計將推動醫院獲得性疾病檢測的進一步進步。

醫院獲得性疾病檢測市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 15.90% 左右的複合年成長率成長

基於感染類型細分，尿路感染。預計在 2023 年實現最大市場佔有率

基於檢測技術細分，PCR（聚合酶鍊式反應）。是2023年的主導類型

根據測試類型細分，分子診斷是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

醫院獲得性疾病檢測市場-細分分析：

全球醫院獲得性疾病檢測市場根據感染類型、檢測技術、檢測類型、最終用戶和地區進行細分。

依感染類型，市場分為四類：泌尿道感染、手術部位感染、呼吸道感染、血流感染。泌尿道感染（UTI）因其在醫療機構中的盛行率而排名最高，其次是手術部位感染，這是術後的關鍵問題。其次是呼吸道感染，其中血流感染最不常見，但也很嚴重。

根據測試技術，市場分為四類：PCR（聚合酶鍊式反應）、ELISA（酵素連結免疫吸附測定）、微生物培養和快速診斷。 PCR（聚合酶鍊式反應）因其準確性和速度而領先，其次是廣泛用於抗體檢測的 ELISA（酶聯免疫吸附測定）。微生物培養位居第二，快速診斷的優先順序最低。

醫院獲得性疾病檢測市場-地理洞察

醫院獲得性疾病檢測市場呈現出顯著的地區差異，其中北美領先，因為其先進的醫療基礎設施和院內感染(HAI) 的高發生率，大約每31 名住院患者中就有1 人受到感染。在嚴格的法規和感染控制措施意識增強的推動下，歐洲緊隨其後。在亞太地區，快速的城市化和醫療設施的擴張促進了市場的成長，特別是在印度和中國等國家，院內感染正成為一個緊迫的問題。世界衛生組織的全球感染預防和控制網路等措施旨在加強資源匱乏地區醫院感染的監測和管理，進一步刺激需求。同時，隨著醫院升級檢測能力以應對不斷上升的感染率，拉丁美洲和中東地區的感染率也不斷成長。這些地區擴大採用先進的診斷技術，展現了提高醫療機構病患安全和照護品質的全球趨勢。

醫院獲得性疾病檢測市場-競爭格局：

醫院獲得性疾病檢測市場的特點是競爭格局激烈，雅培實驗室、羅氏診斷公司和生物梅里埃等主要參與者在北美處於領先地位，北美由於其廣泛的醫療保健系統和對診斷技術的大量投資而成為主導地區。歐洲緊隨其後，西門子 Healthineers 和賽默飛世爾科技 (Thermo Fisher Scientific) 等公司正在透過策略合作夥伴關係和感染檢測方法的創新來鞏固自己的地位。在亞太地區，由於院內感染發生率不斷上升，印度和中國等國家不斷提高檢測能力，以滿足不斷成長的需求，本土企業不斷湧現。值得注意的是，印度政府推出了加強醫院感染控制措施的舉措，進一步推動了市場成長。同時，在拉丁美洲和中東，公司正致力於擴大其分銷網路並提高對 HAI 的認知，從而促進市場動態。總體而言，競爭格局的特點是創新和策略合作，旨在改善不同醫療保健環境中的患者治療結果。

最新進展：

2021 年 11 月，PINC AI™ Applied Sciences 和 Molnlycke Health Care AB 啟動了一項臨床試驗，以評估 Molnlycke 的 Mepilex Border Flex 敷料在減少急診環境中醫院獲得性壓力性損傷 (HAPI) 方面的有效性。

目錄

第1章：醫院獲得性疾病檢測市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按感染類型分類的醫院獲得性疾病檢測市場片段
    • 醫院獲得性疾病檢測市場片段（按檢測技術）
    • 按測試類型分類的醫院獲得性疾病檢測市場片段
    • 最終用戶的醫院獲得性疾病檢測市場片段
    • 按國家/地區分類的醫院獲得性疾病檢測市場片段
    • 按地區分類的醫院獲得性疾病檢測市場片段
  • 競爭洞察

第 3 章：醫院獲得性疾病檢測主要市場趨勢

  • 醫院獲得性疾病檢測市場促進因素
    • 市場促進因素的影響分析
  • 醫院獲得性疾病檢測市場限制
    • 市場限制影響分析
  • 醫院獲得性疾病檢測市場機會
  • 醫院獲得性疾病檢測市場未來趨勢

第 4 章：醫院獲得性疾病檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：醫院獲得性疾病檢測市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：醫院獲得性疾病檢測市場格局

  • 2023 年醫院獲得性疾病檢測市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：醫院獲得性疾病檢測市場 - 按感染類型

  • 概述
    • 按感染類型分類的細分市場佔有率分析
    • 泌尿道感染
    • 手術部位感染
    • 呼吸道感染
    • 血流感染

第 8 章：醫院獲得性疾病檢測市場 - 按檢測技術分類

  • 概述
    • 透過測試技術進行細分市場佔有率分析
    • PCR（聚合酶鍊式反應）
    • ELISA（酵素連結免疫吸附測定）
    • 微生物培養
    • 快速診斷

第 9 章：醫院獲得性疾病檢測市場 - 按檢測類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 分子診斷
    • 免疫測定
    • 常規培養測試

第 10 章：醫院獲得性疾病檢測市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診斷實驗室
    • 門診手術中心
    • 學術及研究機構

第 11 章：醫院獲得性疾病檢測市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美醫院獲得性疾病檢測主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按感染類型）
    • 北美市場規模和預測（按測試技術）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲醫院獲得性疾病檢測主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按感染類型）
    • 歐洲市場規模和預測（透過測試技術）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區醫院獲得性疾病檢測主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按感染類型）
    • 按測試技術分類的亞太市場規模和預測
    • 按測試類型分類的亞太市場規模和預測
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲醫院獲得性疾病檢測主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按感染類型）
    • 拉丁美洲市場規模和預測（透過測試技術）
    • 拉丁美洲市場規模和預測（按測試類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲醫院獲得性疾病檢測主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按感染類型）
    • 中東和非洲市場規模及預測（按測試技術）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第12章：主要供應商分析-醫院獲得性疾病檢測產業

  • 競爭儀表板
  • 公司簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Cardinal Health, Inc.
    • Cepheid Inc. (A Danaher Company)
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • GenMark Diagnostics, Inc.
    • Hologic, Inc.
    • Luminex Corporation
    • Merck KGaA
    • Qiagen NV
    • QuidelOrtho Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3983

REPORT HIGHLIGHT

Hospital-Acquired Disease Testing Market size was valued at USD 12,290.32 Million in 2023, expanding at a CAGR of 15.90% from 2024 to 2032.

The Hospital-Acquired Disease Testing Market focuses on diagnostic tests for infections acquired in healthcare settings, impacting patient safety and hospital resources. Rising incidences of hospital-acquired infections (HAIs), such as MRSA and C. difficile, emphasize the need for effective testing solutions; for instance, HAIs affect approximately 1 in 31 hospital patients in the U.S., highlighting significant challenges for healthcare providers. Increasing awareness about infection control and advancements in molecular diagnostics are key drivers for market growth. However, factors such as high testing costs and stringent regulatory frameworks may hinder adoption. Opportunities abound in developing innovative rapid testing methods and expanding testing capabilities, particularly in emerging markets where healthcare infrastructure is improving. As hospitals prioritize patient safety and regulatory compliance, investments in advanced testing technologies are expected to rise, fostering a more proactive approach to infection management.

Hospital-Acquired Disease Testing Market- Market Dynamics

Rising Incidences of Hospital-Acquired Infections Propel Demand for Advanced Testing Solutions in the Hospital-Acquired Disease Testing Market

The rising incidence of hospital-acquired infections (HAIs) has significantly increased the demand for advanced testing solutions in healthcare settings. These infections, such as urinary tract infections (UTIs), surgical site infections, and bloodstream infections, pose severe risks to patient health and have led to extended hospital stays and higher mortality rates. According to the Centers for Disease Control and Prevention (CDC), HAIs affect millions of patients annually, prompting the development of more precise and rapid diagnostic tools. Governments and healthcare organizations worldwide have launched initiatives to combat HAIs. For instance, the World Health Organization (WHO) promotes stringent hygiene protocols, while countries like the UK have introduced financial penalties for hospitals with high infection rates. The increasing focus on real-time, accurate testing methods, such as Polymerase Chain Reaction (PCR) and rapid diagnostic tests, is expected to drive further advancements in hospital-acquired disease testing.

Hospital-Acquired Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.90% over the forecast period (2024-2032)

Based on Infection type segmentation, Urinary Tract Infections. was predicted to show maximum market share in the year 2023

Based on Testing Technology segmentation, PCR (Polymerase Chain Reaction). was the leading type in 2023

Based on Test Type segmentation, Molecular Diagnostics was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hospital-Acquired Disease Testing Market- Segmentation Analysis:

The Global Hospital-Acquired Disease Testing Market is segmented on the basis of Infection type, Testing Technology, Test Type, End-User, and Region.

The market is divided into four categories based on Infection type: Urinary Tract Infections, Surgical Site Infections, Respiratory Infections, and Bloodstream Infections. Urinary Tract Infections (UTIs) rank highest due to their prevalence in healthcare settings, followed by Surgical Site Infections, which are critical post-operative concerns. Respiratory Infections come next, with Bloodstream Infections being the least common yet severe.

The market is divided into four categories based on Testing Technology: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Microbial Culture, and Rapid Diagnostics. PCR (Polymerase Chain Reaction) leads due to its accuracy and speed, followed by ELISA (Enzyme-Linked Immunosorbent Assay), which is widely used for antibody detection. Microbial Culture ranks next, with Rapid Diagnostics being the least prioritized.

Hospital-Acquired Disease Testing Market- Geographical Insights

The Hospital-Acquired Disease Testing Market shows significant regional variation, with North America leading due to its advanced healthcare infrastructure and high incidence of hospital-acquired infections (HAIs), which affect approximately 1 in 31 hospitalized patients. Europe follows closely, driven by stringent regulations and increased awareness of infection control measures. In Asia-Pacific, rapid urbanization and the expansion of healthcare facilities contribute to market growth, particularly in countries like India and China, where hospital-acquired infections are becoming a pressing concern. Initiatives such as the World Health Organization's Global Infection Prevention and Control Network aim to enhance surveillance and management of HAIs in low-resource settings, further stimulating demand. Meanwhile, Latin America and the Middle East are witnessing growth as hospitals upgrade their testing capabilities to combat rising infection rates. These regions are increasingly adopting advanced diagnostic technologies, showcasing a global trend towards improving patient safety and quality of care in healthcare settings.

Hospital-Acquired Disease Testing Market- Competitive Landscape:

The Hospital-Acquired Disease Testing Market is characterized by a competitive landscape with key players such as Abbott Laboratories, Roche Diagnostics, and bioMerieux leading in North America, which is the dominant region due to its extensive healthcare systems and significant investment in diagnostic technologies. Europe follows, where companies like Siemens Healthineers and Thermo Fisher Scientific are strengthening their positions through strategic partnerships and innovations in infection detection methods. In the Asia-Pacific region, local players are emerging, driven by the increasing prevalence of hospital-acquired infections, with countries like India and China ramping up their testing capabilities to meet rising demand. Notably, the Indian government has launched initiatives to enhance infection control practices in hospitals, further boosting market growth. Meanwhile, in Latin America and the Middle East, companies are focusing on expanding their distribution networks and increasing awareness about HAIs, contributing to market dynamics. Overall, the competitive landscape is marked by innovation and strategic collaborations aimed at improving patient outcomes across diverse healthcare settings.

Recent Developments:

In November 2021, PINC AI(TM) Applied Sciences and Molnlycke Health Care AB launched a clinical trial to evaluate the effectiveness of Molnlycke's Mepilex Border Flex dressings in reducing hospital-acquired pressure injuries (HAPIs) in acute care settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • Cepheid Inc. (A Danaher Company)
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Luminex Corporation
  • Merck KGaA
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY INFECTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Urinary Tract Infections
  • Surgical Site Infections
  • Respiratory Infections
  • Bloodstream Infections

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TESTING TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR (Polymerase Chain Reaction)
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • Microbial Culture
  • Rapid Diagnostics

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassays
  • Conventional Culture Tests

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Ambulatory Surgery Centers
  • Academic & Research Institutes

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hospital-Acquired Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hospital-Acquired Disease Testing Market Snippet by Infection type
    • 2.1.2. Hospital-Acquired Disease Testing Market Snippet by Testing Technology
    • 2.1.3. Hospital-Acquired Disease Testing Market Snippet by Test Type
    • 2.1.4. Hospital-Acquired Disease Testing Market Snippet by End-User
    • 2.1.5. Hospital-Acquired Disease Testing Market Snippet by Country
    • 2.1.6. Hospital-Acquired Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Hospital-Acquired Disease Testing Key Market Trends

  • 3.1. Hospital-Acquired Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hospital-Acquired Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hospital-Acquired Disease Testing Market Opportunities
  • 3.4. Hospital-Acquired Disease Testing Market Future Trends

4. Hospital-Acquired Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hospital-Acquired Disease Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hospital-Acquired Disease Testing Market Landscape

  • 6.1. Hospital-Acquired Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hospital-Acquired Disease Testing Market - By Infection type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Infection type, 2023 & 2032 (%)
    • 7.1.2. Urinary Tract Infections
    • 7.1.3. Surgical Site Infections
    • 7.1.4. Respiratory Infections
    • 7.1.5. Bloodstream Infections

8. Hospital-Acquired Disease Testing Market - By Testing Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Technology, 2023 & 2032 (%)
    • 8.1.2. PCR (Polymerase Chain Reaction)
    • 8.1.3. ELISA (Enzyme-Linked Immunosorbent Assay)
    • 8.1.4. Microbial Culture
    • 8.1.5. Rapid Diagnostics

9. Hospital-Acquired Disease Testing Market - By Test Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 9.1.2. Molecular Diagnostics
    • 9.1.3. Immunoassays
    • 9.1.4. Conventional Culture Tests

10. Hospital-Acquired Disease Testing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Ambulatory Surgery Centers
    • 10.1.5. Academic & Research Institutes

11. Hospital-Acquired Disease Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hospital-Acquired Disease Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hospital-Acquired Disease Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hospital-Acquired Disease Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Hospital-Acquired Disease Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Hospital-Acquired Disease Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hospital-Acquired Disease Testing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Becton, Dickinson and Company
    • 12.2.3. bioMerieux S.A.
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. Cardinal Health, Inc.
    • 12.2.6. Cepheid Inc. (A Danaher Company)
    • 12.2.7. Danaher Corporation
    • 12.2.8. F. Hoffmann-La Roche AG
    • 12.2.9. GenMark Diagnostics, Inc.
    • 12.2.10. Hologic, Inc.
    • 12.2.11. Luminex Corporation
    • 12.2.12. Merck KGaA
    • 12.2.13. Qiagen N.V.
    • 12.2.14. QuidelOrtho Corporation
    • 12.2.15. Siemens Healthineers AG
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us